Pure Cycle (PCYO) Stock Chart & Stock Price History → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free PCYO Stock Alerts $9.85 -0.06 (-0.61%) (As of 01:22 PM ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Pure Cycle Stock Price Performance5 Day Performance-0.61%1 Month Performance+1.86%3 Month Performance+0.20%6 Month Performance+0.61%Year-To-Date Performance-5.92%1 Year Performance+7.30% Receive PCYO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pure Cycle and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsFidelity, Bezos, Goldman Bet Big on Tiny BiotechAre you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.Don't miss out on the "next Ozempic" >>> PCYO Stock Chart for Wednesday, May, 8, 2024 PCYO Chart by TradingView Pure Cycle Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/07/2024$9.91$9.91$9.93$9.8231,476 shs$238.73 million05/06/2024$9.91$9.91$9.98$9.8732,364 shs$238.73 million05/03/2024$9.78$9.91+1.33%$10.03$9.8350,829 shs$238.73 million05/02/2024$9.54$9.78+2.52%$9.84$9.56112,212 shs$235.60 million05/01/2024$9.54$9.54$9.76$9.5445,463 shs$229.82 million04/30/2024$9.49$9.54+0.53%$9.56$9.3072,794 shs$229.82 million Get the Latest News and Ratings for PCYO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pure Cycle and its competitors with MarketBeat's FREE daily newsletter. 04/29/2024$9.50$9.49-0.11%$9.50$9.4329,588 shs$228.61 million04/26/2024$9.49$9.50+0.11%$9.55$9.4647,953 shs$228.86 million04/25/2024$9.57$9.49-0.84%$9.62$9.4582,136 shs$228.61 million04/24/2024$9.50$9.57+0.74%$9.60$9.3445,483 shs$230.54 million04/23/2024$9.64$9.50-1.45%$9.78$9.3743,698 shs$228.86 million04/22/2024$9.53$9.64+1.15%$9.69$9.5640,958 shs$232.23 million04/19/2024$9.29$9.53+2.58%$9.56$9.2739,830 shs$229.58 million04/18/2024$9.37$9.29-0.85%$9.42$9.2942,363 shs$223.80 million04/17/2024$9.54$9.37-1.78%$9.54$9.2841,502 shs$225.72 million04/16/2024$9.50$9.54+0.42%$9.60$9.4155,312 shs$229.82 million04/15/2024$9.66$9.50-1.66%$9.80$9.3575,168 shs$228.85 million04/12/2024$9.68$9.66-0.21%$9.72$9.4361,097 shs$232.61 million04/11/2024$9.51$9.68+1.79%$9.84$9.50197,641 shs$233.10 million04/10/2024$9.69$9.51-1.86%$9.60$9.31106,201 shs$229.01 million04/09/2024$9.67$9.69+0.21%$9.75$9.5323,142 shs$233.34 million04/08/2024$9.60$9.67+0.73%$9.91$9.6174,054 shs$232.85 million04/05/2024$9.47$9.60+1.37%$9.66$9.3530,630 shs$231.17 million04/04/2024$9.35$9.47+1.28%$9.54$9.3171,128 shs$228.04 million04/03/2024$9.36$9.35-0.11%$9.52$9.3149,947 shs$225.15 million04/02/2024$9.54$9.36-1.89%$9.56$9.3354,869 shs$225.39 million04/01/2024$9.50$9.54+0.42%$9.60$9.4128,141 shs$229.72 million03/29/2024$9.50$9.50$9.67$9.5029,034 shs$228.76 million03/28/2024$9.54$9.50-0.42%$9.67$9.5029,025 shs$228.76 million03/27/2024$9.25$9.54+3.14%$9.56$9.2725,371 shs$229.72 million03/26/2024$9.33$9.25-0.86%$9.32$9.2430,778 shs$222.74 million03/25/2024$9.46$9.33-1.37%$9.57$9.3126,753 shs$224.67 million03/22/2024$9.57$9.46-1.15%$9.71$9.4628,458 shs$227.80 million03/21/2024$9.46$9.57+1.22%$9.61$9.4432,593 shs$230.45 million03/20/2024$9.33$9.46+1.34%$9.62$9.2536,095 shs$227.68 million03/19/2024$9.20$9.33+1.41%$9.43$9.1724,991 shs$224.67 million03/18/2024$9.30$9.20-1.08%$9.67$9.2033,617 shs$221.54 million03/15/2024$9.29$9.30+0.11%$9.48$9.22145,062 shs$223.94 million03/14/2024$9.54$9.29-2.62%$9.51$9.2956,679 shs$223.70 million03/13/2024$9.87$9.54-3.34%$9.88$9.5036,668 shs$229.72 millionThe Weight Loss Pill That Could Disrupt a $32 Billion Industry (Ad)A revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results.Don't miss out on the "next Ozempic" >>>03/12/2024$10.00$9.87-1.30%$10.00$9.8749,100 shs$237.67 million03/11/2024$10.00$10.00$10.04$9.8724,286 shs$240.80 million03/08/2024$9.93$10.00+0.70%$10.12$9.8658,123 shs$240.80 million03/07/2024$9.74$9.93+1.95%$9.99$9.8227,513 shs$239.11 million03/06/2024$9.85$9.74-1.12%$9.94$9.7326,805 shs$234.54 million03/05/2024$9.88$9.85-0.30%$10.09$9.8334,147 shs$237.19 million03/04/2024$9.89$9.88-0.10%$10.07$9.8050,795 shs$237.91 million03/01/2024$9.97$9.89-0.80%$10.06$9.8443,156 shs$238.15 million02/29/2024$9.82$9.97+1.53%$10.11$9.8847,352 shs$240.08 million02/28/2024$9.85$9.82-0.30%$10.02$9.7350,916 shs$236.47 million02/27/2024$9.94$9.85-0.91%$10.03$9.8351,588 shs$237.19 million02/26/2024$9.95$9.94-0.10%$10.00$9.7541,658 shs$239.37 million02/23/2024$10.07$9.95-1.19%$10.15$9.9029,583 shs$239.60 million02/22/2024$9.85$10.07+2.23%$10.11$9.6572,976 shs$242.49 million02/21/2024$10.06$9.85-2.09%$10.10$9.7753,305 shs$237.19 million02/20/2024$10.02$10.06+0.40%$10.32$9.9542,042 shs$242.25 million02/19/2024$10.02$10.02$10.32$9.9690,600 shs$241.28 million02/16/2024$10.35$10.02-3.19%$10.32$9.9690,602 shs$241.28 million02/15/2024$10.04$10.35+3.09%$10.47$10.2076,415 shs$249.23 million02/14/2024$9.54$10.04+5.24%$10.05$9.5791,059 shs$241.76 million02/13/2024$10.01$9.54-4.70%$9.83$9.4188,545 shs$229.72 million02/12/2024$9.69$10.01+3.30%$10.07$9.6568,346 shs$241.04 million02/09/2024$9.83$9.69-1.42%$9.86$9.6534,729 shs$233.34 million02/08/2024$9.89$9.83-0.61%$9.99$9.7567,682 shs$236.71 million02/07/2024$9.70$9.89+1.96%$10.04$9.6093,385 shs$238.15 million Related Companies: GWRS Stock Chart ARTNA Stock Chart CWCO Stock Chart YORW Stock Chart MSEX Stock Chart BROG Stock Chart GNE Stock Chart CNSL Stock Chart CLNE Stock Chart SHEN Stock Chart Receive PCYO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pure Cycle and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PCYO) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pure Cycle Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.